Tracleer (Actelion Pharmaceuticals US, Inc.)
Welcome to the PulseAid listing for the Tracleer drug offered from Actelion Pharmaceuticals US, Inc.. This Endothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actelion Pharmaceuticals US, Inc. |
| NON-PROPRIETARY NAME: | bosentan |
| SUBSTANCE NAME: | BOSENTAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Endothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2001-11-20 |
| END MARKETING DATE: | 0000-00-00 |
Tracleer HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tracleer from Actelion Pharmaceuticals US, Inc. |
| LABELER NAME: | Actelion Pharmaceuticals US, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 62.5(mg/1) |
| START MARKETING DATE: | 2001-11-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66215-101_f5877d4f-ce06-46df-889c-2798d528edc6 |
| PRODUCT NDC: | 66215-101 |
| APPLICATION NUMBER: | NDA021290 |
Other BOSENTAN Pharmaceutical Manufacturers / Labelers:
